Net Loss per Share

12 Months Ended

Dec. 31, 2021

Earnings Per Share [Abstract]

Net Loss per Share

23. Net Loss per Share

As a result of the Business Combination, the Company has retroactively restated the weighted average shares outstanding prior to September 16, 2021 to give effect to the Exchange Ratio.

The Company computes net loss per share of the Class A common stock and Class B common stock using the two-class method required for participating securities. The earnings per share amounts are the same for the different classes of common stock because the holders of each class are legally entitled to equal per share distributions whether through dividends or liquidation. The calculation of basic and diluted earnings per common share are as follows (in thousands, except per share amounts):

	Year ended December 31,
	2021			2020			2019
Numerator:
Net loss attributable to Ginkgo Bioworks Holdings, Inc. stockholders, basic	$	(1,830,047	)	$	(126,609	)	$	(119,327	)
Change in fair value of warrant liabilities	$	58,615			—			—
Net loss attributable to Ginkgo Bioworks Holdings, Inc. stockholders, diluted	$	(1,888,662	)	$	(126,609	)	$	(119,327	)
Denominator
Weighted average common shares outstanding, basic		1,359,848,803			1,274,766,915			1,149,000,417
Weighted average effect of dilutive outstanding warrants		524,540			—			—
Weighted average common shares outstanding, diluted		1,360,373,343			1,274,766,915			1,149,000,417
Basic net loss per share	$	(1.35	)	$	(0.10	)	$	(0.10	)
Diluted net loss per share	$	(1.39	)	$	(0.10	)	$	(0.10	)

The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to Ginkgo Bioworks Holdings, Inc. common stockholders for the periods presented because including them would have been anti-dilutive:

	As of December 31,
	2021		2020		2019
Warrants to purchase Class A common stock		—		1,020,187		1,020,187
Outstanding stock options		25,228,853		33,354,871		35,276,812
Unvested RSUs		168,321,952		124,932,207		70,119,944
Unvested RSAs		182,622		419,049		675,887
New Ginkgo and Sponsor earnout shares (1)		160,995,237		—		—
		354,728,664		159,726,314		107,092,830

(1) Represents earnout shares for which the vesting conditions have not been satisfied.